The Centers for Disease Control and Prevention opioid guideline revisions and pharmacy practice: An opinion of the American College of Clinical Pharmacy Pain and Palliative Care Practice and Research Network

Abstract The Centers for Disease Control and Prevention revised their Clinical Practice Guideline for Prescribing Opioids for Pain in 2022. This opinion paper was prepared by members of the American College of Clinical Pharmacy (ACCP) Pain and Palliative Care Practice and Research Network (PRN) and provides an overview of updates to the 2022 guidelines, highlighting major changes from the 2016 guidelines and calling attention to the opportunities and challenges for pharmacists in providing patient‐centered care with opioids for pain management. While this paper represents the opinion of the ACCP Pain and Palliative Care PRN, it does not necessarily represent an official ACCP commentary, guideline, or statement of policy or position.

Authors

Institutions

Publication Details

Journal
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
Published
2024-12-20
DOI
https://doi.org/10.1002/jac5.2067
Citations
1
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.54
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Centers for Disease Control and Prevention opioid guideline revisions and pharmacy practice: An opinion of the American College of Clinical Pharmacy Pain and Palliative Care Practice and Research Network

M. Gabrielle Pagé, Megan Carr, Katherine N. Theken, N. Carolyn Love et al.
1 citations
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
Opioid Use Disorder Treatment
0.54
article

The Centers for Disease Control and Prevention opioid guideline revisions and pharmacy practice: An opinion of the American College of Clinical Pharmacy Pain and Palliative Care Practice and Research Network

M. Gabrielle Pagé, Megan Carr, Katherine N. Theken, N. Carolyn Love, Katherine M. Juba, Dominick P. Trombetta, Victoria Tutag Lehr, Jessica Emshoff, Emily Uebbing, Hannah Denham
article en
1 citations

Abstract

Abstract The Centers for Disease Control and Prevention revised their Clinical Practice Guideline for Prescribing Opioids for Pain in 2022. This opinion paper was prepared by members of the American College of Clinical Pharmacy (ACCP) Pain and Palliative Care Practice and Research Network (PRN) and provides an overview of updates to the 2022 guidelines, highlighting major changes from the 2016 guidelines and calling attention to the opportunities and challenges for pharmacists in providing patient‐centered care with opioids for pain management. While this paper represents the opinion of the ACCP Pain and Palliative Care PRN, it does not necessarily represent an official ACCP commentary, guideline, or statement of policy or position.

JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACYVol. 8(3)
High Point University (US), Eugene Applebaum College of Pharmacy and Health Sciences (US), Indiana University Health (US), Strong Memorial Hospital (US), Wilkes University (US), Wayne State University (US), Robinson Memorial Hospital (US), Health Net (US), University of Rochester Medical Center (US), Albany Stratton VA Medical Center Albany (US), Allied Services (US), Conemaugh Memorial Medical Center (US), Indiana University – Purdue University Indianapolis (US), University of Pennsylvania (US), Northeast Ohio Medical University (US)
Good health and well-being
Openalex Percentile: Top 26%
Opioid Use Disorder Treatment
0.54
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.